|Bid||13.55 x 1800|
|Ask||13.59 x 1800|
|Day's Range||13.45 - 13.71|
|52 Week Range||12.30 - 28.74|
|Beta (3Y Monthly)||0.66|
|PE Ratio (TTM)||436.45|
|Earnings Date||Feb 25, 2019 - Mar 1, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.67|
Altria Group Inc., Liberty Global, Diplomat Pharmacy Inc. and Cyanotech Corp have declined to their respective three-year lows
NEW YORK, Jan. 10, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
FLINT, Mich., Jan. 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (DPLO), is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat will provide limited-distribution drugs and specialty care management solutions to health system clients.
The nation's largest independent provider of specialty pharmacy services is partnering with CSI Specialty Group to provide specialty pharmacy solutions for hospitals and health systems. FLINT, Mich., Jan. 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (DPLO), and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting or expanding their own specialty pharmacy services to benefit from Diplomat's limited-distribution drug portfolio and expertise treating rare, chronic, and complex diseases. CSI, a partner of leading national healthcare solutions organization and Intermountain Healthcare company Intalere, offers specialty pharmacy solutions to help health systems improve patient care and optimize access to specialty medications.
Pharmacy benefit manager Hospitality Rx has selected Diplomat as the exclusive specialty pharmacy for its UNITE HERE HEALTH plan members. FLINT, Mich., Jan. 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (DPLO), has been selected by Hospitality Rx as the exclusive provider of specialty pharmacy and infusion services for its UNITE HERE HEALTH (UHH) plan members.
Diplomat Pharmacy, Inc. (NYSE:DPLO) is a small-cap stock with a market capitalization of US$1.0b. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they Read More...
Inovalon signed a deal with a top 10 specialty pharmacy likely worth "multimillions" on Thursday, according to one analyst — prompting shares of the medical software maker to pop midday.
FLINT, Mich. , Dec. 19, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at this year's J.P. Morgan Healthcare Conference in San Francisco . Diplomat's Brian Griffin, ...
RICHMOND, Va., Nov. 29, 2018 /PRNewswire/ -- Diplomat Pharmacy, the largest independent provider of specialty pharmacy services in the United States, has committed to moving their cold chain shipments away from EPS foam by utilizing TemperPack's ClimaCell™ insulating technology. ClimaCell coolers are fully curbside recyclable alongside cardboard. ClimaCell is the first certified recyclable shipping cooler of its kind with thermal performance equivalent to that of EPS on an inch for inch basis.
BOWIE, Md., Nov. 28, 2018 -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced.
The nation's largest independent provider of specialty pharmacy and infusion services partners with TemperPack to ship using 100% curbside recyclable ClimaCell™ coolers. FLINT, Mich., Nov. 26, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (DPLO), is now shipping temperature-sensitive medication in ClimaCell™ coolers from TemperPack. ClimaCell coolers are fully recyclable at curbside and insulated with renewable materials that can be recycled wherever plastic bags are accepted.
If you own shares in Diplomat Pharmacy Inc (NYSE:DPLO) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure Read More...
NEW YORK, Nov. 09, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
In late afternoon trading, the markets are relatively calm and up sharply despite the news that Attorney General Jeff Sessions has announced his resignation. Although the resignation of Senator Sessions has arguably been expected by many, the gravity of the move could potentially lead to unexpected situations down the road that could affect stock prices. Among […]
Diplomat Pharmaceuticals (DPLO) delivered earnings and revenue surprises of -100.00% and -4.69%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Flint, Michigan-based company said it had profit of less than 1 cent on a per-share basis. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 22 cents per ...
3rd Quarter Revenue of $1,373 Million , an increase of 22%, Net Income Attributable to Diplomat of $0.2 Million compared to $1.0 Million , Adjusted EBITDA of $41.9 Million , an increase of 81% FLINT, Mich. ...
On Tuesday, Nov. 6, Diplomat Pharmacy (NYSE: DPLO ) will release its latest earnings report. Benzinga's outlook for Diplomat Pharmacy is included in the following report. Earnings and Revenue Wall Street ...
FLINT, Mich. , Oct. 16, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its third-quarter 2018 operating results after market close Tuesday, Nov. 6 , with a conference call to follow ...